Conjugates wherein the antibody being the modifying agent and wherein the linker

Official title: {Conjugates wherein the antibody being the modifying agent and wherein the linker, binder or spacer confers particular properties to the conjugates, e.g. peptidic enzyme-labile linkers or acid-labile linkers, providing for an acid-labile immuno conjugate wherein the drug may be released from its antibody conjugated part in an acidic, e.g. tumoural or environment}

A61K47/6889 (Conjugates wherein the antibody being the modifying agent and wherein the linker) appears on 1,108 US grants and 2,488 published applications in this corpus.